O21 HCV reinfection and injecting risk behaviour following elbasvir/grazoprevir treatment in patients on opioid agonist therapy: Co-STAR three year follow-up study

• Main Authors: G. Dore (Author), J. Grebely (Author), F. Altice (Author), A.H. Litwin (Author), O. Dalgard (Author), E.J. Gane (Author), O. Shibolet (Author), A. Luetkemeyer (Author), R. Nahass (Author), C.Y. Peng (Author), B. Conway (Author), D.M. Iser (Author), H.C. Huang (Author), I.N. Gendrano (Author), M. Kelly (Author), P. Hwang (Author), M. Robertson (Author), J. Wahl (Author), E. Barr (Author), H.L. Platt (Author)
• Format: Book
• Published: Elsevier, 2017-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Item Description

2055-6640
10.1016/S2055-6640(20)30904-3